E. Zafar et al., “Alantolactone: A Potential Multitarget Drug candidate for Prevention of SARS-CoV-2 Cell Entry”, J Mol Docking, vol. 2, no. 2, Dec. 2022, doi: 10.33084/jmd.v2i2.3679.